Loading...

PODCAST

Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

science life sciences

All Episodes

2:32

Pharmaceutical Executive Daily: September 4, 2025

Pharmaceutical Executive ·

2025/09/04

In today’s Pharmaceutical Executive Daily, we cover political pressure on Moderna and Novavax to release COVID-19 vaccine evidence, a deep dive into the evolving GLP-1 market, and Sanofi’s share decline following disappointing Phase III results for Amlitelimab.

en-us

2:09

Pharmaceutical Executive Daily: September 3, 2025

Pharmaceutical Executive ·

2025/09/03

In today’s Pharmaceutical Executive Daily, we cover Pfizer’s response to political pressure over COVID-19 vaccine safety data, Cheryl Reicin’s outlook on future GLP-1 investment, and Novartis’ $5.2 billion acquisition of Argo Biopharmaceuticals.

en-us

14:39

The Rx for High-Performance Leadership: Cutting...

Pharmaceutical Executive ·

2025/08/22

In a turbulent era for biopharma, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, shares high-level insights on what CEOs can do to thrive amid the disruption—from regulatory agility to cultural resilience. The corporate strategy expert explains why the best leaders are the best learners—and how prioritization, honesty, and boldness will separate those who merely survive from those who

en-us

2:08

Pharmaceutical Executive Weekly:CSL Cuts Jobs,...

Pharmaceutical Executive ·

2025/08/21

In this week’s Pharmaceutical Executive Weekly, we cover CSL’s decision to cut 15% of its U.S. workforce and close 22 plasma centers, Pfizer’s Phase 3 trial failure in sickle cell disease, and Eli Lilly’s new LillyDirect program expanding full-dose Zepbound access for obesity patients.

en-us

17:26

Addressing Disparities in Psoriasis Trials: Takeda's...

Pharmaceutical Executive ·

2025/04/14

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis trials. She also talks about Takeda's partnerships with community stakeholders like Inside Edge, Black Health Matters, and Hispanic Communication Global Network to help improve engagement, address operational barriers by incorporating multicultural imagery, and prioritize sites with diverse patient demographics. She also explains how they've enhanced

en-us

17:36

Tariffs and Drug Prices: Understanding the Impact on...

Pharmaceutical Executive ·

2025/03/24

In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses:The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts. How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts The importance of telehealth in ensuring

en-us

24:22

The Misinformation Maze: Navigating Public Health in...

Pharmaceutical Executive ·

2025/03/11

In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses: The threat of misinformation to public health and how emotional appeal plays a part Where patients are turning for trustworthy health information Strategies that can be used to verify information Pharma's role in helping to ensure patients have access to health insights they can trust Why the industry is turning to peer-to-patient platforms, trusted patient communities, and

en-us

26:45

Navigating Distrust: Pharma in the Age of Social Media

Pharmaceutical Executive ·

2025/02/18

In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss:The growing distrust in social media Why people trust friends and influencers over companies The EMA's departure from X Concerns about information accessibility The healthcare industry's trust gap "Dark Social" and SO MUCH MORE! Pharmaceutical Executive has a brand new look! Click through our February issue here:

en-us

19:23

Revolutionizing Patient Adherence: Leveraging AI for...

Pharmaceutical Executive ·

2025/02/10

In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence. By utilizing patient-level data and predictive modeling, AI can identify individual needs and preferences, tailoring interventions to optimize treatment outcomes. This personalized approach addresses the common challenges of medication non-adherence and improves patient outcomes. The discussion highlights the importance of

en-us

30:12

The Future of Fertility: AI, Personalized Medicine,...

Pharmaceutical Executive ·

2025/01/30

In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the challenges of addressing fertility misinformation on social media. He emphasizes the importance of providing accurate and reliable information and encourages patients to consult with healthcare professionals. He also discusses the ethical considerations of using social media to share personal and professional experiences in the field of fertility

en-us

13:20

Key Findings of the NIAGARA and HIMALAYA Trials

Pharmaceutical Executive ·

2024/11/08

In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.

en-us

21:15

Fake Weight Loss Drugs: Growing Threat to Consumer...

Pharmaceutical Executive ·

2024/10/25

UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks What can be done to raise awareness among consumers about the dangers of counterfeit medications Ways increase access to legitimate weight loss medications, especially for those in underserved communities and much more!

en-us

14:52

A Different Approach to Dermatology Care

Pharmaceutical Executive ·

2024/09/23

Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses how is they're positioning to capitalize on the unmet needs in other specific therapeutic areas, their approach to orphan drug development, challenges and opportunities adapting to the US market, and more.

en-us

15:48

Beyond the Birthrate: The Societal Costs of Maternal...

Pharmaceutical Executive ·

2024/09/06

In this episode of the Pharmaceutical Executive podcast, Charlotte Owens, MD, FACOG, Head of Medical Affairs and Outcomes Research at Organon discusses:The broader societal implications of these maternal health issues highlighted in The Commonwealth Fund study The most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make Specific efforts Organon is undertaking to invest in research, education, and its pipeline to focus on critical

en-us

18:39

Empty Shelves, Urgent Solutions

Pharmaceutical Executive ·

2024/08/05

Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of both large and independent pharmacies, what alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities), some potential long term consequences if these pharmacy closures continue, and so much more

en-us

17:10

The Weight-Loss Gold Rush: Legal and Regulatory...

Pharmaceutical Executive ·

2024/07/11

Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses:Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs What needs to be done for GLP-1s to be covered Steps companies developing weight-loss medications should take to ensure responsible and ethical practice Advice for investors

en-us

13:10

Healthcare Marketing Strategies for Reaching Diverse...

Pharmaceutical Executive ·

2024/05/14

Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.Link to Honeycomb Health video: https://www.pharmexec.com/view/going-beyond-visuals-to-connect-with-diverse-audiences

en-us

22:37

A Decade in the Anti-Obesity Arena

Pharmaceutical Executive ·

2024/04/30

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.

en-us

16:18

Fierce Females in the Life Science Space

Pharmaceutical Executive ·

2024/03/28

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands. Featured in this episode are: Emma Banks, CEO, ramarketing Jill Jaroch, Senior Director, Women’s Health & Urology Marketing, Astellas Marie Teil, Global Head, UCB’s Women of Childbearing Age Program Julia Lakeland, Chief Product

en-us

20:32

Gen-Z Influence on Pharma M&A

Pharmaceutical Executive ·

2024/03/14

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses their recent data and research about some massive behavioral shifts occurring across Gen-Z, and how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract the ever elusive generation.

en-us

463 results

Similar Podcasts

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

La Science CQFD

France Culture

A Moment of Science

Indiana Public Media

Meteorology Matters

Rob Jones

The Deep Dive Lab: Unraveling Materials Science

Son Hoang